Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Signal Transduction and Targeted Therapy | MAPK14 promotes smooth muscle cell degeneration in abdominal aortic aneurysm through transcriptional regulation
2026-01-15
【Frontier Express】Hepatology | IL-8-CXCR2 Pathway Mediates Neutrophil NET Formation and Promotes Biliary Fibrosis
2026-01-15
【Frontier Express】Cancer Research | SPP1 Drives Colorectal Cancer Liver Metastasis and Resistance to Immunotherapy
2026-01-14
【Frontier Express】Circulation Research | Role of Nonmuscle α-Actinin 4 in Cardiac Remodeling
2026-01-14
【Frontier Express】Cyborg and Bionic Systems | Nano-Immunotherapy Synergizes Ferroptosis and STING Activation for Metastatic Bladder Cancer
2026-01-12
【Frontier Express】Advanced Materials | Bi-Functional Topospecific Nanoparticles to Promote Immune-Tumor Cell Engagement as A New Immunotherapeutic Strategy
2026-01-12
【Frontier Express】Nature Neuroscience | Lecanemab attenuates Aβ pathology through microglial activation
2026-01-11






